Dynamic (11)C-Methionine PET-CT: Prognostic Factors for Disease Progression and Survival in Patients with Suspected Glioma Recurrence

SIMPLE SUMMARY: Recurrence after initial treatments is an expected event in glioma patients, particularly for high-grade glioma, with a median progression-free survival of 8–11 weeks. The prognostic evaluation of disease is a crucial step in the planning of therapeutic strategies, in both the primar...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattoli, Maria Vittoria, Trevisi, Gianluca, Scolozzi, Valentina, Capotosti, Amedeo, Cocciolillo, Fabrizio, Marini, Irene, Mare, Valerio, Indovina, Luca, Caulo, Massimo, Saponiero, Antonella, Balducci, Mario, Taralli, Silvia, Calcagni, Maria Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508090/
https://www.ncbi.nlm.nih.gov/pubmed/34638262
http://dx.doi.org/10.3390/cancers13194777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508090/
https://www.ncbi.nlm.nih.gov/pubmed/34638262
http://dx.doi.org/10.3390/cancers13194777

Ejemplares similares